Device Trial Radar · NCT06784063
Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)
Last checked: Nov 20, 2026Latest source record: Jul 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Apr 10, 2025
Primary completion
Jun 13, 2025
Study completion Jun 13, 2025
Sponsor
- Lead sponsor
- Alcon ResearchNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 20, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to generate clinical data to quantify the impact of residual astigmatism on the overall visual performance during distance, intermediate, and near viewing in patients implanted with Clareon Vivity IOLs.
Conditions
- Astigmatism
Interventions
Clareon Vivity Extended Vision IOLDevice
Extended vision intraocular lens implanted in the capsular bag of the eye during cataract surgery. IOLs are intended for long term use over the lifetime of the cataract patient.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Difference in Monocular Best Corrected Distance Visual Acuity (BCDVA) (4 Meters) Before and After Inducing 1.0 Diopter (D) Astigmatism - WTRTime frame: Day 0 before induced astigmatism; Day 0 after induced astigmatism
- Mean Difference in Monocular Distance Corrected Intermediate Visual Acuity (DCIVA) (66 Centimeters) Before and After Inducing 1.0 D Astigmatism - WTRTime frame: Day 0 before induced astigmatism; Day 0 after induced astigmatism
- Mean Difference in Monocular Distance Corrected Near Visual Acuity (DCNVA) (40 cm) Before and After Inducing 1.0 D Astigmatism - WTRTime frame: Day 0 before induced astigmatism; Day 0 after induced astigmatism
3 more outcomes with a free account
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Grosinger, Spigelman & Grey Eye Surgeons, P.C
Bloomfield Hills, Michigan
Key-Whitman Eye Center
Dallas, Texas
Berkeley Eye Center
Sugar Land, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.